Join our team as a postdoc at the University of Minnesota!
Global deaths due to limited access to treatment for end stage kidney disease (ESKD) is estimated to reach 9.1 million by 2030. This burden is overwhelmingly felt by patients in low and middle income communities. Our team, which includes partner nephrologists in the U.S. and in Nigeria, has identified peritoneal dialysis (PD) as the path toward increased access. However, limited availability of peritoneal dialysate has limited the impact of past attempts to introduce PD as a treatment modality.
The Wright Research Group is seeking a postdoctoral associate with a background in microbiology, biology, molecular biology, biochemistry, cell biology, or equivalent to help us advance our biopharmaceutical device for rapid, on-demand compounding of the dialysate, near the point of care.
The device being developed is currently going through tech translation towards a start-up company. Interest in entrepreneurship and tech translation is a plus.
Application is live at the following link:
https://hr.myu.umn.edu/jobs/ext/368707